[卵巢癌的药物治疗]
[Pharmacotherapy in ovarian carcinoma].
作者信息
Pfisterer J, Du Bois A
机构信息
Klinik für Gynäkologie und Geburtshilfe, Campus Kiel, Universitätsklinikum Schleswig-Holstein.
出版信息
MMW Fortschr Med. 2005 Oct 27;147(43):34-6.
PMID:16302419
Abstract
Pharmacotherapy in Ovarian Carcinoma Although recent years have seen considerable progress in the treatment of primary and recurrent ovarian carcinoma, the mortality rate continues to be very high. Possibilities for improvement include compliance with the current treatment recommendations both in the surgical and medical areas, as well as the participation in clinical studies or treatment in study centers.
摘要
卵巢癌的药物治疗 尽管近年来在原发性和复发性卵巢癌的治疗方面取得了相当大的进展，但死亡率仍然非常高。改进的可能性包括在手术和医疗领域遵守当前的治疗建议，以及参与临床研究或在研究中心接受治疗。
相似文献
1
[Pharmacotherapy in ovarian carcinoma].
MMW Fortschr Med. 2005 Oct 27;147(43):34-6.
2
Recent advances in the management of women with ovarian cancer.
Minerva Ginecol. 2004 Feb;56(1):81-9.
3
Chemotherapy for ovarian cancer: an evidence-based approach.
Minerva Ginecol. 2004 Dec;56(6):539-45.
4
Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
J Natl Compr Canc Netw. 2004 Sep;2 Suppl 2:S60-73.
5
[Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
Zentralbl Gynakol. 1997;119(7):299-323.
6
Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Acta Obstet Gynecol Scand. 2008;87(12):1343-52. doi: 10.1080/00016340802495491.
7
Ifosfamide in the treatment of ovarian cancer.
Semin Oncol. 1996 Jun;23(3 Suppl 6):47-9.
8
Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
Gynecol Oncol. 2006 Oct;103(1):1-6. doi: 10.1016/j.ygyno.2006.06.026. Epub 2006 Aug 10.
9
Quality of life in ovarian cancer patients receiving chemotherapy.
Gynecol Oncol. 2001 Jun;81(3):490-5. doi: 10.1006/gyno.2001.6199.
10
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
Crit Rev Oncol Hematol. 2008 Jun;66(3):229-36. doi: 10.1016/j.critrevonc.2007.12.005. Epub 2008 Feb 1.
Zotero 插件